Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 174-179

  Du, Lanying ^a   Kao, Richard Y ^a   Zhou, Yusen ^b   He, Yuxian ^c   Zhao, Guangyu ^a,b   Wong, Charlotte ^a   Jiang, Shibo ^c   Yuen, Kwok Yung ^a   Jin, Dong Yan ^a   Zheng, Bo Jian ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

Cleavage of S protein; Protease Factor Xa; Protease inhibitor; SARS CoV; Spike protein

Indexed keywords

PROTEIN S; PROTEINASE; VIRUS PROTEIN;

ARTICLE; DISEASE ASSOCIATION; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; RECEPTOR BINDING; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INFECTION;

CELL LINE; FACTOR XA; HUMANS; KIDNEY; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; VIRAL ENVELOPE PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

SARS CORONAVIRUS;

EID: 34249740996     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.092     Document Type: Article

References (24)

1. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., and Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003) 1319-1325
2. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
3. Liu S., Xiao G., Chen Y., He Y., Niu J., Escalante C.R., Xiong H., Farmar J., Debnath A.K., Tien P., and Jiang S. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363 (2004) 938-947
4. Mounir S., and Talbot P.J. Molecular characterization of the S protein gene of human coronavirus OC43. J. Gen. Virol. 74 Pt. 9 (1993) 1981-1987
5. Abraham S., Kienzle T.E., Lapps W., and Brian D.A. Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site. Virology 176 (1990) 296-301
6. Zelus B.D., Schickli J.H., Blau D.M., Weiss S.R., and Holmes K.V. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J. Virol. 77 (2003) 830-840
7. Sturman L.S., Ricard C.S., and Holmes K.V. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion. J. Virol. 64 (1990) 3042-3050
8. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., and Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 (2003) 1394-1399
9. Wu X.D., Shang B., Yang R.F., Yu H., Ma Z.H., Shen X., Ji Y.Y., Lin Y., Wu Y.D., Lin G.M., Tian L., Gan X.Q., Yang S., Jiang W.H., Dai E.H., Wang X.Y., Jiang H.L., Xie Y.H., Zhu X.L., Pei G., Li L., Wu J.R., and Sun B. The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. Cell Res. 14 (2004) 400-406
10. Follis K.E., York J., and Nunberg J.H. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 350 (2006) 358-369
11. Zheng B.J., Guan Y., Hez M.L., Sun H., Du L., Zheng Y., Wong K.L., Chen H., Chen Y., Lu L., Tanner J.A., Watt R.M., Niccolai N., Bernini A., Spiga O., Woo P.C., Kung H.F., Yuen K.Y., and Huang J.D. Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir. Ther. 10 (2005) 393-403
12. Kao R.Y., Tsui W.H., Lee T.S., Tanner J.A., Watt R.M., Huang J.D., Hu L., Chen G., Chen Z., Zhang L., He T., Chan K.H., Tse H., To A.P., Ng L.W., Wong B.C., Tsoi H.W., Yang D., Ho D.D., and Yuen K.Y. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem. Biol. 11 (2004) 1293-1299
13. He Y., Li J., Li W., Lustigman S., Farzan M., and Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J. Immunol. 176 (2006) 6085-6092
14. Du L., He Y., Wang Y., Zhang H., Ma S., Wong C.K., Wu S.H.W., Ng F., Huang J.D., Yuen K.Y., Jiang S., Zhou Y., and Zheng B.J. Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: implication for developing SARS vaccines. Virology 353 (2006) 6-16
15. He Y., Li J., Heck S., Lustigman S., and Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. J. Virol. 80 (2006) 5757-5767
16. Cui J., Crich D., Wink D., Lam M., Rheingold A.L., Case D.A., Fu W., Zhou Y., Rao M., Olson A.J., and Johnson M.E. Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)-diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketones. Bioorg. Med. Chem. 11 (2003) 3379-3392
17. Quan M.L., and Wexler R.R. The design and synthesis of noncovalent factor Xa inhibitors. Curr. Top. Med. Chem. 1 (2001) 137-149
18. Hung H.L., Pollak E.S., Kudaravalli R.D., Arruda V., Chu K., and High K.A. Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors. Blood 97 (2001) 946-951
19. He Y., Lu H., Siddiqui P., Zhou Y., and Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J. Immunol. 174 (2005) 4908-4915
20. Du L., Zhao G., He Y., Guo Y., Zheng B.J., Jiang S., and Zhou Y. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine 25 (2007) 2832-2838
21. Sha Y., Wu Y., Cao Z., Xu X., Wu W., Jiang D., Mao X., Liu H., Zhu Y., Gong R., and Li W. A convenient cell fusion assay for the study of SARS-CoV entry and inhibition. IUBMB Life 58 (2006) 480-486
22. Chen L., Gui C., Luo X., Yang Q., Gunther S., Scandella E., Drosten C., Bai D., He X., Ludewig B., Chen J., Luo H., Yang Y., Yang Y., Zou J., Thiel V., Chen K., Shen J., Shen X., and Jiang H. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 79 (2005) 7095-7103
23. Han Y.S., Chang G.G., Juo C.G., Lee H.J., Yeh S.H., Hsu J.T., and Chen X. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry 44 (2005) 10349-10359
24. Frick D.N., and Lam A.M. Understanding helicases as a means of virus control. Curr. Pharm. Des. 12 (2006) 1315-1338